US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Prime Medicine, Inc.

1.69

+0.330024.26%

Post-market: 1.68-0.0100-0.59%19:55 EDT

Volume:4.96M

Turnover:8.02M

Market Cap:216.02M

PE:-1.05

High:1.71

Open:1.42

Low:1.40

Close:1.36

Loading ...

Overview Company News Filings

Prime Medicine Inc. Conducted Annual Stockholders Meeting Virtually

Prime Medicine Cut to Neutral From Buy by Citigroup

Prime Medicine Inc : Citigroup Cuts to Neutral From Buy; Cuts Target Price to $1.5 From $10

THOMSON REUTERS

Prime Medicine downgraded to Neutral from Buy at Citi

Hold Rating for Prime Medicine, Inc. Amid Financial Uncertainties and Strategic Adjustments

CEO Allan Reine Reports Acquisition of Common Shares of Prime Medicine Inc

HC Wainwright Downgrades Prime Medicine to Neutral From Buy

MT Newswires Live

Prime Medicine Cut to Neutral From Buy by HC Wainwright & Co.

Prime Medicine downgraded to Neutral from Buy at H.C. Wainwright

Prime Medicine, Inc. : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS

Prime Medicine Inc : JP Morgan Cuts to Neutral From Overweight

THOMSON REUTERS

Prime Medicine Is Maintained at Buy by Chardan Capital

Prime Medicine price target lowered to $12 from $16 at Chardan

Wedbush Adjusts Prime Medicine Price Target to $8 From $13, Maintains Outperform Rating

MT Newswires Live

Prime Medicine Inc : Jefferies Cuts Target Price to $9 From $13

THOMSON REUTERS

Prime Medicine Cuts Jobs, Names New CEO in Strategic Pivot

Prime Medicine, Inc.: Strategic Shifts and Leadership Changes Bolster Long-term Buy Rating Amid Near-term Volatility

Prime Medicine to Cut Costs, Focus on Liver Treatment Programs; New CEO Named

MT Newswires Live

Prime Medicine Reports Positive Initial Data From First Patient Dosed in Potential Granulomatous Disease Drug Study

MT Newswires Live

BRIEF-Prime Medicine Announces Strategic Restructuring To Focus On Opportunities In Large Genetic Liver Diseases, Cystic Fibrosis, And Partnered Programs Alongside CEO Leadership Transition

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PRME/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRME","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRME\",,,,,undefined,":{"symbol":"PRME","market":"US","secType":"STK","nameCN":"Prime Medicine, Inc.","latestPrice":1.69,"timestamp":1749240000000,"preClose":1.36,"halted":0,"volume":4961828,"hourTrading":{"tag":"盘后","latestPrice":1.68,"preClose":1.69,"latestTime":"19:55 EDT","volume":120421,"amount":199140.4471,"timestamp":1749254137205},"delay":0,"floatShares":60552549,"shares":127821911,"eps":-1.613442,"marketStatus":"Market Closed","change":0.33,"latestTime":"06-06 16:00:00 EDT","open":1.42,"high":1.71,"low":1.4,"amount":8017389.163260801,"amplitude":0.227941,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.613442,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1666238400000,"exchange":"NASDAQ","adjPreClose":1.36,"dividendRate":0.000592,"preHourTrading":{"tag":"盘前","latestPrice":1.41,"preClose":1.36,"latestTime":"09:24 EDT","volume":507433,"amount":715569.6859780999,"timestamp":1749216293145},"postHourTrading":{"tag":"盘后","latestPrice":1.68,"preClose":1.69,"latestTime":"19:55 EDT","volume":120421,"amount":199140.4471,"timestamp":1749254137205},"volumeRatio":3.214357801457705,"impliedVol":2.0935,"impliedVolPercentile":0.832},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRME\",,,,,undefined,":{"symbol":"PRME","floatShares":60552549,"roa":"-40.36%","roe":"-115.21%","lyrEps":-1.651613,"volumeRatio":3.214357801457705,"shares":127821911,"dividePrice":0.001,"high":1.71,"amplitude":0.227941,"preClose":1.36,"low":1.4,"week52Low":1.11,"pbRate":"2.02","psRate":"56.17","week52High":8.1442,"institutionHeld":0,"latestPrice":1.69,"eps":-1.613442,"divideRate":0.000592,"volume":4961828,"delay":0,"ttmEps":-1.613442,"open":1.42,"prevYearClose":2.92,"prevWeekClose":1.18,"prevMonthClose":1.18,"prevQuarterClose":1.99,"fiveDayClose":1.18,"twentyDayClose":1.32,"sixtyDayClose":1.91},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PRME\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541005539","title":"Prime Medicine Inc. Conducted Annual Stockholders Meeting Virtually","url":"https://stock-news.laohu8.com/highlight/detail?id=2541005539","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541005539?lang=en_us&edition=fundamental","pubTime":"2025-06-06 04:12","pubTimestamp":1749154340,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prime Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 05, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDLbRbLlt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2538557469","title":"Prime Medicine Cut to Neutral From Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2538557469","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538557469?lang=en_us&edition=fundamental","pubTime":"2025-05-27 20:40","pubTimestamp":1748349600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRME/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 27, 2025 08:40 ET (12:40 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME"],"gpt_icon":0},{"id":"2538457046","title":"Prime Medicine Inc : Citigroup Cuts to Neutral From Buy; Cuts Target Price to $1.5 From $10","url":"https://stock-news.laohu8.com/highlight/detail?id=2538457046","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538457046?lang=en_us&edition=fundamental","pubTime":"2025-05-27 18:19","pubTimestamp":1748341185,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nFWN3RZ0LR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2538486524","title":"Prime Medicine downgraded to Neutral from Buy at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2538486524","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538486524?lang=en_us&edition=fundamental","pubTime":"2025-05-27 07:55","pubTimestamp":1748303716,"startTime":"0","endTime":"0","summary":"Citi downgraded Prime Medicine (PRME) to Neutral from Buy with a price target of $1.50, down from $10. The shares are trading near cash, reflecting...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/prime-medicine-downgraded-to-neutral-from-buy-at-citi-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/prime-medicine-downgraded-to-neutral-from-buy-at-citi-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2538485826","title":"Hold Rating for Prime Medicine, Inc. Amid Financial Uncertainties and Strategic Adjustments","url":"https://stock-news.laohu8.com/highlight/detail?id=2538485826","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538485826?lang=en_us&edition=fundamental","pubTime":"2025-05-27 06:45","pubTimestamp":1748299513,"startTime":"0","endTime":"0","summary":"Prime Medicine, Inc. (PRME – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Samantha Semenk...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/hold-rating-for-prime-medicine-inc-amid-financial-uncertainties-and-strategic-adjustments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/hold-rating-for-prime-medicine-inc-amid-financial-uncertainties-and-strategic-adjustments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRME"],"gpt_icon":0},{"id":"2537226859","title":"CEO Allan Reine Reports Acquisition of Common Shares of Prime Medicine Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2537226859","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537226859?lang=en_us&edition=fundamental","pubTime":"2025-05-23 04:19","pubTimestamp":1747945159,"startTime":"0","endTime":"0","summary":"Reine Allan, Chief Executive Officer and Director of Prime Medicine Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prime Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nNDL97j4Tp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2536461459","title":"HC Wainwright Downgrades Prime Medicine to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2536461459","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536461459?lang=en_us&edition=fundamental","pubTime":"2025-05-20 19:39","pubTimestamp":1747741151,"startTime":"0","endTime":"0","summary":"Prime Medicine (PRME) has an average rating of overweight and mean price target of $8.44, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRME"],"gpt_icon":0},{"id":"2536611839","title":"Prime Medicine Cut to Neutral From Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2536611839","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536611839?lang=en_us&edition=fundamental","pubTime":"2025-05-20 19:07","pubTimestamp":1747739220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRME/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 20, 2025 07:07 ET (11:07 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME"],"gpt_icon":0},{"id":"2536615478","title":"Prime Medicine downgraded to Neutral from Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2536615478","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536615478?lang=en_us&edition=fundamental","pubTime":"2025-05-20 18:15","pubTimestamp":1747736145,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Arthur He downgraded Prime Medicine (PRME) to Neutral from Buy without a price target The company decided to discontinue th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/prime-medicine-downgraded-to-neutral-from-buy-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/prime-medicine-downgraded-to-neutral-from-buy-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2536615503","title":"Prime Medicine, Inc. : H.c. Wainwright Cuts to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2536615503","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536615503?lang=en_us&edition=fundamental","pubTime":"2025-05-20 18:10","pubTimestamp":1747735835,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nAZN3V5ER4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2536663007","title":"Prime Medicine Inc : JP Morgan Cuts to Neutral From Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2536663007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536663007?lang=en_us&edition=fundamental","pubTime":"2025-05-20 11:22","pubTimestamp":1747711340,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250520:nFWN3RR2SM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2536631178","title":"Prime Medicine Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2536631178","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536631178?lang=en_us&edition=fundamental","pubTime":"2025-05-20 01:33","pubTimestamp":1747675980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRME/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 19, 2025 13:33 ET (17:33 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME"],"gpt_icon":0},{"id":"2536960631","title":"Prime Medicine price target lowered to $12 from $16 at Chardan","url":"https://stock-news.laohu8.com/highlight/detail?id=2536960631","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536960631?lang=en_us&edition=fundamental","pubTime":"2025-05-20 01:20","pubTimestamp":1747675240,"startTime":"0","endTime":"0","summary":"Chardan analyst Geulah Livshits lowered the firm’s price target on Prime Medicine (PRME) to $12 from $16 and keeps a Buy rating on the shares after...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/prime-medicine-price-target-lowered-to-12-from-16-at-chardan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/prime-medicine-price-target-lowered-to-12-from-16-at-chardan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2536639313","title":"Wedbush Adjusts Prime Medicine Price Target to $8 From $13, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2536639313","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536639313?lang=en_us&edition=fundamental","pubTime":"2025-05-20 00:27","pubTimestamp":1747672073,"startTime":"0","endTime":"0","summary":"Prime Medicine (PRME) has an average rating of Buy and mean price target of $9.33, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRME"],"gpt_icon":0},{"id":"2536638521","title":"Prime Medicine Inc : Jefferies Cuts Target Price to $9 From $13","url":"https://stock-news.laohu8.com/highlight/detail?id=2536638521","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536638521?lang=en_us&edition=fundamental","pubTime":"2025-05-19 22:16","pubTimestamp":1747664174,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nFWN3RR2IU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2536820496","title":"Prime Medicine Cuts Jobs, Names New CEO in Strategic Pivot","url":"https://stock-news.laohu8.com/highlight/detail?id=2536820496","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536820496?lang=en_us&edition=fundamental","pubTime":"2025-05-19 21:24","pubTimestamp":1747661040,"startTime":"0","endTime":"0","summary":"Prime Medicine is cutting 25% of its workforce and bringing in a new chief executive as it pivots to focus on its liver franchise and programs that aren't internally funded.The biotechnology company said Monday that it is deprioritizing its chronic granulomatous disease programs as part of a major overhaul that should cut its operating costs and cash burn almost in half through 2027.In tandem with the restructuring, Keith Gottesdiener is departing as chief executive and a member of Prime's board.Allan Reine, the company's chief financial officer, has been named CEO and will become a member of the board. Jeff Marrazzo, another director, has been named executive chair.Prime's shares fell 8.2% to $1.46 in premarket trading.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Prime Medicine Cuts Jobs, Names New CEO in Strategic Pivot","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2536820306","title":"Prime Medicine, Inc.: Strategic Shifts and Leadership Changes Bolster Long-term Buy Rating Amid Near-term Volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2536820306","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536820306?lang=en_us&edition=fundamental","pubTime":"2025-05-19 21:15","pubTimestamp":1747660514,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Soumit Roy has maintained their bullish stance on PRME stock, giving a Buy rating on May 9. Soumit Roy has given his Buy ratin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/prime-medicine-inc-strategic-shifts-and-leadership-changes-bolster-long-term-buy-rating-amid-near-term-volatility?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/prime-medicine-inc-strategic-shifts-and-leadership-changes-bolster-long-term-buy-rating-amid-near-term-volatility?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRME"],"gpt_icon":0},{"id":"2536981682","title":"Prime Medicine to Cut Costs, Focus on Liver Treatment Programs; New CEO Named","url":"https://stock-news.laohu8.com/highlight/detail?id=2536981682","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536981682?lang=en_us&edition=fundamental","pubTime":"2025-05-19 21:11","pubTimestamp":1747660315,"startTime":"0","endTime":"0","summary":"Prime Medicine  said Monday it is implementing a strategic restructuring program, including the reduction in cost and workforce and the deprioritization of its chronic granulomatous disease programs.The company said it is focusing on its liver franchise and programs funded through external partnerships. These include the development of in vivo programs for the treatment of Wilson's Disease and Alpha-1 Antitrypsin Deficiency, with initial clinical data from both programs expected in 2027.The cost reduction measures, which include laying off about 25% of its workforce, will cut cash needs by almost half throughout 2027, the company said. Prime said its cash, cash equivalents and investments as of March 31 will be sufficient to fund its operations and capital expenditure requirements into the first half of 2026.Prime has also appointed Allan Reine as the company's chief executive officer and Jeff Marrazzo as its executive chair. Reine succeeds Keith Gottesdiener, who has decided to step d","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2536596682","title":"Prime Medicine Reports Positive Initial Data From First Patient Dosed in Potential Granulomatous Disease Drug Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2536596682","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536596682?lang=en_us&edition=fundamental","pubTime":"2025-05-19 21:07","pubTimestamp":1747660052,"startTime":"0","endTime":"0","summary":"Prime Medicine (PRME) on Monday reported positive initial data from the first patient dosed in its ongoing Phase 1/2 clinical study of PM359 for the potential treatment of chronic granulomatous diseas","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2536810846","title":"BRIEF-Prime Medicine Announces Strategic Restructuring To Focus On Opportunities In Large Genetic Liver Diseases, Cystic Fibrosis, And Partnered Programs Alongside CEO Leadership Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2536810846","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536810846?lang=en_us&edition=fundamental","pubTime":"2025-05-19 20:35","pubTimestamp":1747658127,"startTime":"0","endTime":"0","summary":"BRIEF-Prime Medicine Announces Strategic Restructuring To Focus On Opportunities In Large Genetic Liver Diseases, Cystic Fibrosis, And Partnered Programs Alongside CEO Leadership TransitionMay 19 (Reu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nTUA785ZVQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BRIEF-Prime Medicine Announces Strategic Restructuring To Focus On Opportunities In Large Genetic Liver Diseases, Cystic Fibrosis, And Partnered Programs Alongside CEO Leadership Transition","news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":56,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRME\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"PRME","fiscalQuarterEnding":"2025/03","expectedEps":-0.32,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.4}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRME\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRME\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":12,"updateTime":1748318400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PRME\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PRME","date":"2025-06-06","current":-0.860536,"percent":0.960443,"low":-12.570387,"twenty":-9.59913,"median":-4.020065,"eighty":-1.858801,"high":-0.737151,"avg":-5.273247,"sd":3.498481,"marketCap":173837798},"quantilePoints":[{"date":"2022-10-21","current":-8.113391,"twenty":-8.464693,"median":-8.289042,"eighty":-8.033081,"marketCap":1341687112},{"date":"2022-10-28","current":-9.601189,"twenty":-8.641295,"median":-8.448017,"eighty":-8.033081,"marketCap":1587719838},{"date":"2022-11-04","current":-10.409439,"twenty":-9.977,"median":-8.685445,"eighty":-8.202968,"marketCap":1721377754},{"date":"2022-11-11","current":-10.872767,"twenty":-10.427972,"median":-9.596041,"eighty":-8.373885,"marketCap":1797996942},{"date":"2022-11-18","current":-11.552132,"twenty":-10.872767,"median":-9.86889,"eighty":-8.458023,"marketCap":1680246066},{"date":"2022-11-25","current":-12.332199,"twenty":-11.490203,"median":-10.239552,"eighty":-8.464693,"marketCap":1793705981},{"date":"2022-12-02","current":-10.349281,"twenty":-11.187493,"median":-10.319508,"eighty":-8.641295,"marketCap":1505292610},{"date":"2022-12-09","current":-10.045591,"twenty":-10.872767,"median":-10.307599,"eighty":-9.081232,"marketCap":1461121193},{"date":"2022-12-16","current":-10.033682,"twenty":-10.868215,"median":-10.164685,"eighty":-9.444687,"marketCap":1459388980},{"date":"2022-12-23","current":-10.617243,"twenty":-10.856622,"median":-10.102289,"eighty":-9.5981,"marketCap":1544267390},{"date":"2022-12-30","current":-11.063846,"twenty":-10.872767,"median":-10.200413,"eighty":-9.61504,"marketCap":1609225356},{"date":"2023-01-06","current":-9.986044,"twenty":-10.872767,"median":-10.254006,"eighty":-9.670445,"marketCap":1452460130},{"date":"2023-01-13","current":-9.503713,"twenty":-10.861386,"median":-10.164685,"eighty":-9.670445,"marketCap":1382305527},{"date":"2023-01-20","current":-9.819312,"twenty":-10.851859,"median":-10.069665,"eighty":-9.588294,"marketCap":1428209156},{"date":"2023-01-27","current":-10.390964,"twenty":-10.806603,"median":-10.07847,"eighty":-9.600159,"marketCap":1511355353},{"date":"2023-02-03","current":-12.570387,"twenty":-10.851859,"median":-10.134912,"eighty":-9.656594,"marketCap":1828350230},{"date":"2023-02-10","current":-11.742683,"twenty":-10.982862,"median":-10.245074,"eighty":-9.675208,"marketCap":1707961465},{"date":"2023-02-17","current":-11.165076,"twenty":-11.402074,"median":-10.277825,"eighty":-9.686245,"marketCap":1623949162},{"date":"2023-02-24","current":-10.140867,"twenty":-11.343717,"median":-10.295689,"eighty":-9.727769,"marketCap":1474978892},{"date":"2023-03-03","current":-9.813358,"twenty":-11.222241,"median":-10.274847,"eighty":-9.713478,"marketCap":1427343050},{"date":"2023-03-10","current":-10.050095,"twenty":-11.104338,"median":-10.254006,"eighty":-9.674017,"marketCap":1224312632},{"date":"2023-03-17","current":-8.918099,"twenty":-11.003108,"median":-10.200413,"eighty":-9.59913,"marketCap":1086411714},{"date":"2023-03-24","current":-8.134409,"twenty":-10.908707,"median":-10.134912,"eighty":-9.535868,"marketCap":990941849},{"date":"2023-03-31","current":-8.925355,"twenty":-10.872767,"median":-10.07847,"eighty":-9.430442,"marketCap":1087295695},{"date":"2023-04-06","current":-8.279537,"twenty":-10.868215,"median":-10.050821,"eighty":-9.350566,"marketCap":1008621453},{"date":"2023-04-14","current":-9.367995,"twenty":-10.856622,"median":-10.045591,"eighty":-9.178488,"marketCap":1141218489},{"date":"2023-04-21","current":-9.716301,"twenty":-10.838758,"median":-10.039636,"eighty":-9.219247,"marketCap":1183649541},{"date":"2023-04-28","current":-9.897711,"twenty":-10.785166,"median":-10.017793,"eighty":-9.345724,"marketCap":1205749047},{"date":"2023-05-05","current":-10.96942,"twenty":-10.785166,"median":-10.021772,"eighty":-9.354933,"marketCap":1336305690},{"date":"2023-05-12","current":-8.073848,"twenty":-10.735146,"median":-10.027727,"eighty":-9.345724,"marketCap":1109169075},{"date":"2023-05-19","current":-8.52077,"twenty":-10.701531,"median":-9.990007,"eighty":-9.099515,"marketCap":1170566377},{"date":"2023-05-26","current":-8.827649,"twenty":-10.681401,"median":-9.975498,"eighty":-9.032416,"marketCap":1212724706},{"date":"2023-06-02","current":-9.637285,"twenty":-10.630075,"median":-9.897711,"eighty":-8.989982,"marketCap":1323950937},{"date":"2023-06-09","current":-9.800518,"twenty":-10.71371,"median":-9.971839,"eighty":-9.02363,"marketCap":1346375580},{"date":"2023-06-16","current":-9.800518,"twenty":-10.686434,"median":-9.86695,"eighty":-9.031944,"marketCap":1346375580},{"date":"2023-06-23","current":-9.767872,"twenty":-10.642906,"median":-9.849086,"eighty":-9.068318,"marketCap":1341890652},{"date":"2023-06-30","current":-9.696049,"twenty":-10.612479,"median":-9.825267,"eighty":-9.106778,"marketCap":1332023809},{"date":"2023-07-07","current":-8.971294,"twenty":-10.602192,"median":-9.819312,"eighty":-9.099515,"marketCap":1232458393},{"date":"2023-07-14","current":-9.545874,"twenty":-10.585619,"median":-9.810202,"eighty":-9.137267,"marketCap":1311393137},{"date":"2023-07-21","current":-9.78093,"twenty":-10.559433,"median":-9.800518,"eighty":-9.17528,"marketCap":1343684623},{"date":"2023-07-28","current":-9.330407,"twenty":-10.517007,"median":-9.791764,"eighty":-9.19176,"marketCap":1281792608},{"date":"2023-08-04","current":-8.977823,"twenty":-10.501721,"median":-9.787459,"eighty":-9.17528,"marketCap":1233355378},{"date":"2023-08-11","current":-7.351426,"twenty":-10.465993,"median":-9.782257,"eighty":-9.044383,"marketCap":1105764783},{"date":"2023-08-18","current":-7.175671,"twenty":-10.456327,"median":-9.761342,"eighty":-8.9726,"marketCap":1079328527},{"date":"2023-08-25","current":-7.708998,"twenty":-10.45472,"median":-9.735225,"eighty":-8.925402,"marketCap":1159548890},{"date":"2023-09-01","current":-8.024145,"twenty":-10.44932,"median":-9.716301,"eighty":-8.912293,"marketCap":1206951832},{"date":"2023-09-08","current":-7.469607,"twenty":-10.444557,"median":-9.701789,"eighty":-8.700407,"marketCap":1123540886},{"date":"2023-09-15","current":-7.660513,"twenty":-10.432557,"median":-9.68952,"eighty":-8.613331,"marketCap":1152256130},{"date":"2023-09-22","current":-6.799918,"twenty":-10.420738,"median":-9.68299,"eighty":-8.464693,"marketCap":1022809634},{"date":"2023-09-29","current":-5.757506,"twenty":-10.409439,"median":-9.671604,"eighty":-8.402895,"marketCap":866015288},{"date":"2023-10-06","current":-5.387814,"twenty":-10.390964,"median":-9.643814,"eighty":-8.183215,"marketCap":810407990},{"date":"2023-10-13","current":-4.030254,"twenty":-10.389027,"median":-9.630354,"eighty":-8.073848,"marketCap":606210701},{"date":"2023-10-20","current":-4.472673,"twenty":-10.38501,"median":-9.604638,"eighty":-7.912615,"marketCap":672757139},{"date":"2023-10-27","current":-3.627229,"twenty":-10.370718,"median":-9.601189,"eighty":-7.834415,"marketCap":545589631},{"date":"2023-11-03","current":-4.018133,"twenty":-10.337372,"median":-9.572309,"eighty":-7.747785,"marketCap":604387511},{"date":"2023-11-10","current":-3.675264,"twenty":-10.30998,"median":-9.557305,"eighty":-7.702937,"marketCap":631311146},{"date":"2023-11-17","current":-3.3021,"twenty":-10.293236,"median":-9.519757,"eighty":-7.529606,"marketCap":567211621},{"date":"2023-11-24","current":-3.898089,"twenty":-10.287686,"median":-9.505205,"eighty":-7.382941,"marketCap":669586402},{"date":"2023-12-01","current":-3.898089,"twenty":-10.280204,"median":-9.486275,"eighty":-7.272639,"marketCap":669586402},{"date":"2023-12-08","current":-4.596094,"twenty":-10.277825,"median":-9.467523,"eighty":-7.212034,"marketCap":789484793},{"date":"2023-12-15","current":-4.977312,"twenty":-10.27187,"median":-9.460993,"eighty":-7.0484,"marketCap":854967761},{"date":"2023-12-22","current":-4.703479,"twenty":-10.257579,"median":-9.4285,"eighty":-6.653253,"marketCap":807930700},{"date":"2023-12-29","current":-5.127651,"twenty":-10.24686,"median":-9.408438,"eighty":-5.953867,"marketCap":880792030},{"date":"2024-01-05","current":-4.837711,"twenty":-10.236142,"median":-9.364366,"eighty":-5.757506,"marketCap":830988083},{"date":"2024-01-12","current":-4.375954,"twenty":-10.18589,"median":-9.353482,"eighty":-5.296906,"marketCap":751670685},{"date":"2024-01-19","current":-3.430962,"twenty":-10.168926,"median":-9.330407,"eighty":-5.123927,"marketCap":589346709},{"date":"2024-01-26","current":-3.586671,"twenty":-10.164237,"median":-9.238996,"eighty":-4.948317,"marketCap":616093273},{"date":"2024-02-02","current":-3.602779,"twenty":-10.145519,"median":-9.172072,"eighty":-4.834489,"marketCap":618860159},{"date":"2024-02-09","current":-3.613518,"twenty":-10.136103,"median":-9.110409,"eighty":-4.737842,"marketCap":620704750},{"date":"2024-02-16","current":-4.188029,"twenty":-10.111093,"median":-9.030058,"eighty":-4.665393,"marketCap":719390349},{"date":"2024-02-23","current":-5.646822,"twenty":-10.09442,"median":-8.977823,"eighty":-4.688731,"marketCap":969971503},{"date":"2024-03-01","current":-5.767109,"twenty":-10.076709,"median":-8.964765,"eighty":-4.703479,"marketCap":990633618},{"date":"2024-03-08","current":-4.732954,"twenty":-10.058794,"median":-8.925355,"eighty":-4.703479,"marketCap":937754463},{"date":"2024-03-15","current":-4.003242,"twenty":-10.050675,"median":-8.921727,"eighty":-4.668042,"marketCap":793174383},{"date":"2024-03-22","current":-4.267799,"twenty":-10.049482,"median":-8.906197,"eighty":-4.583208,"marketCap":845591862},{"date":"2024-03-28","current":-3.930562,"twenty":-10.04768,"median":-8.700407,"eighty":-4.491687,"marketCap":778773976},{"date":"2024-04-05","current":-3.366561,"twenty":-10.043209,"median":-8.6396,"eighty":-4.407369,"marketCap":667026823},{"date":"2024-04-12","current":-3.37819,"twenty":-10.039636,"median":-8.52077,"eighty":-4.327384,"marketCap":669330888},{"date":"2024-04-19","current":-2.668828,"twenty":-10.037254,"median":-8.464693,"eighty":-4.274777,"marketCap":528782922},{"date":"2024-04-26","current":-2.50199,"twenty":-10.028918,"median":-8.446434,"eighty":-4.188029,"marketCap":495726695},{"date":"2024-05-03","current":-3.264437,"twenty":-10.018588,"median":-8.341216,"eighty":-4.102669,"marketCap":646792703},{"date":"2024-05-10","current":-3.328446,"twenty":-10.004291,"median":-8.200833,"eighty":-4.029746,"marketCap":659474913},{"date":"2024-05-17","current":-3.980486,"twenty":-9.988422,"median":-8.1239,"eighty":-4.009198,"marketCap":813997536},{"date":"2024-05-24","current":-3.923945,"twenty":-9.981826,"median":-8.073848,"eighty":-4.003159,"marketCap":802435071},{"date":"2024-05-31","current":-3.675165,"twenty":-9.974034,"median":-7.993843,"eighty":-3.942726,"marketCap":751560225},{"date":"2024-06-07","current":-3.895675,"twenty":-9.959459,"median":-7.880503,"eighty":-3.91716,"marketCap":796653838},{"date":"2024-06-14","current":-4.466739,"twenty":-9.924575,"median":-7.800381,"eighty":-3.915464,"marketCap":913434735},{"date":"2024-06-21","current":-3.477272,"twenty":-9.903084,"median":-7.757482,"eighty":-3.898089,"marketCap":711091597},{"date":"2024-06-28","current":-3.013635,"twenty":-9.891559,"median":-7.748391,"eighty":-3.898089,"marketCap":616279384},{"date":"2024-07-05","current":-3.019289,"twenty":-9.86695,"median":-7.708998,"eighty":-3.890862,"marketCap":617435631},{"date":"2024-07-12","current":-3.39246,"twenty":-9.849086,"median":-7.702937,"eighty":-3.796073,"marketCap":693747900},{"date":"2024-07-15","current":-3.228491,"twenty":-9.847208,"median":-7.681725,"eighty":-3.778891,"marketCap":660216751},{"date":"2024-08-02","current":-2.934478,"twenty":-9.845329,"median":-7.660513,"eighty":-3.769217,"marketCap":600091933},{"date":"2024-08-09","current":-2.348066,"twenty":-9.837082,"median":-7.542333,"eighty":-3.717006,"marketCap":510561109},{"date":"2024-08-16","current":-2.348066,"twenty":-9.830006,"median":-7.412032,"eighty":-3.67956,"marketCap":510561109},{"date":"2024-08-23","current":-2.214349,"twenty":-9.825267,"median":-7.327184,"eighty":-3.673438,"marketCap":481485875},{"date":"2024-08-30","current":-2.305277,"twenty":-9.822885,"median":-7.242337,"eighty":-3.648578,"marketCap":501257034},{"date":"2024-09-06","current":-2.005751,"twenty":-9.819028,"median":-7.218095,"eighty":-3.633092,"marketCap":436128510},{"date":"2024-09-13","current":-2.166211,"twenty":-9.816984,"median":-7.130217,"eighty":-3.604927,"marketCap":471018790},{"date":"2024-09-20","current":-2.09133,"twenty":-9.812096,"median":-7.0484,"eighty":-3.587408,"marketCap":454736659},{"date":"2024-09-27","current":-1.904126,"twenty":-9.805741,"median":-6.757494,"eighty":-3.549424,"marketCap":414031332},{"date":"2024-10-04","current":-1.823896,"twenty":-9.800518,"median":-6.274989,"eighty":-3.530527,"marketCap":396586191},{"date":"2024-10-11","current":-2.096033,"twenty":-9.800518,"median":-5.960905,"eighty":-3.492172,"marketCap":455759414},{"date":"2024-10-18","current":-2.22484,"twenty":-9.799212,"median":-5.781748,"eighty":-3.439553,"marketCap":483766976},{"date":"2024-10-25","current":-2.459034,"twenty":-9.793099,"median":-5.711575,"eighty":-3.388762,"marketCap":534689815},{"date":"2024-10-31","current":-2.382921,"twenty":-9.789539,"median":-5.646223,"eighty":-3.366561,"marketCap":518139892},{"date":"2024-11-08","current":-2.400485,"twenty":-9.787459,"median":-5.509024,"eighty":-3.3021,"marketCap":521959105},{"date":"2024-11-15","current":-2.09217,"twenty":-9.787459,"median":-5.370213,"eighty":-3.228491,"marketCap":458706110},{"date":"2024-11-22","current":-1.728441,"twenty":-9.783584,"median":-5.278724,"eighty":-3.142239,"marketCap":378958872},{"date":"2024-11-29","current":-1.91467,"twenty":-9.781461,"median":-5.127651,"eighty":-3.10297,"marketCap":419789458},{"date":"2024-12-06","current":-1.728441,"twenty":-9.770484,"median":-5.102719,"eighty":-3.019289,"marketCap":378958872},{"date":"2024-12-13","current":-1.751719,"twenty":-9.762648,"median":-4.977312,"eighty":-2.928824,"marketCap":384062695},{"date":"2024-12-20","current":-1.623687,"twenty":-9.755317,"median":-4.917743,"eighty":-2.820996,"marketCap":355991668},{"date":"2024-12-27","current":-1.710982,"twenty":-9.742659,"median":-4.848449,"eighty":-2.756199,"marketCap":375131005},{"date":"2025-01-03","current":-1.74008,"twenty":-9.735225,"median":-4.829657,"eighty":-2.616428,"marketCap":381510784},{"date":"2025-01-10","current":-1.833195,"twenty":-9.734178,"median":-4.773279,"eighty":-2.565592,"marketCap":401926077},{"date":"2025-01-17","current":-1.670244,"twenty":-9.727254,"median":-4.732954,"eighty":-2.515598,"marketCap":366199314},{"date":"2025-01-24","current":-1.897211,"twenty":-9.716301,"median":-4.703479,"eighty":-2.464888,"marketCap":415961590},{"date":"2025-01-31","current":-1.646965,"twenty":-9.716301,"median":-4.693707,"eighty":-2.41225,"marketCap":361095491},{"date":"2025-02-07","current":-1.466556,"twenty":-9.701789,"median":-4.66661,"eighty":-2.388776,"marketCap":321540861},{"date":"2025-02-14","current":-1.510203,"twenty":-9.696049,"median":-4.603473,"eighty":-2.359501,"marketCap":331110530},{"date":"2025-02-21","current":-1.821555,"twenty":-9.690826,"median":-4.563729,"eighty":-2.345927,"marketCap":399374165},{"date":"2025-02-28","current":-1.408359,"twenty":-9.68952,"median":-4.504816,"eighty":-2.315869,"marketCap":308781303},{"date":"2025-03-07","current":-1.498993,"twenty":-9.68887,"median":-4.469706,"eighty":-2.293509,"marketCap":293625746},{"date":"2025-03-14","current":-1.120986,"twenty":-9.684133,"median":-4.454492,"eighty":-2.239982,"marketCap":219580992},{"date":"2025-03-21","current":-1.30999,"twenty":-9.677717,"median":-4.359151,"eighty":-2.207085,"marketCap":256603369},{"date":"2025-03-28","current":-1.303472,"twenty":-9.67349,"median":-4.342349,"eighty":-2.186856,"marketCap":255326736},{"date":"2025-04-04","current":-1.049295,"twenty":-9.670909,"median":-4.327425,"eighty":-2.138978,"marketCap":205538022},{"date":"2025-04-11","current":-0.762531,"twenty":-9.654364,"median":-4.290045,"eighty":-2.09526,"marketCap":149366140},{"date":"2025-04-17","current":-0.808153,"twenty":-9.646426,"median":-4.267799,"eighty":-2.078568,"marketCap":158302576},{"date":"2025-04-25","current":-1.140538,"twenty":-9.639897,"median":-4.228625,"eighty":-2.052446,"marketCap":223410894},{"date":"2025-05-02","current":-1.134021,"twenty":-9.636803,"median":-4.188029,"eighty":-1.987565,"marketCap":222134260},{"date":"2025-05-09","current":-0.835226,"twenty":-9.629128,"median":-4.164846,"eighty":-1.94144,"marketCap":168724922},{"date":"2025-05-16","current":-0.797262,"twenty":-9.614164,"median":-4.081737,"eighty":-1.913506,"marketCap":161055607},{"date":"2025-05-23","current":-0.778279,"twenty":-9.605765,"median":-4.047395,"eighty":-1.903031,"marketCap":157220950},{"date":"2025-05-30","current":-0.797262,"twenty":-9.603258,"median":-4.028179,"eighty":-1.883244,"marketCap":161055607},{"date":"2025-06-06","current":-0.860536,"twenty":-9.59913,"median":-4.020065,"eighty":-1.858801,"marketCap":173837798}],"updateTime":1749313859144}}}